Trial Profile
Impact of Myfortic on GI Prophylaxis in Maintenance Renal Transplant Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Dec 2009
Price :
$35
*
At a glance
- Drugs Mycophenolate sodium (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions
- Acronyms MPACT
- 09 Dec 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 27 May 2009 New trial record